Filtern
Quelle
  • ariva.de
  • fool.de
  • ntg24.de
  • wallstreet-online.de
Markt
  • Amerika
  • Asien
  • Australien
  • Europa
Index
  • DAX
  • MDAX
  • NASDAQ
  • NYSE
  • SDAX
  • TecDAX
Anlageklasse
  • Aktien
  • Anleihen
  • CFD
  • Derivate
  • ETF
  • Fonds
  • Rohstoffe
  • Währungen
Nachrichtentyp
  • Ad-hoc Mitteilungen
  • Analysen
  • Chartanalysen
  • Empfehlungen
  • IPO Nachrichten
  • Marktberichte
  • Nachrichten
Thema
  • Biotechnologie
  • Finanzdienstleistungen
  • Immobilien
  • Internet
  • Lifestyle
  • Nanotechnologie
  • Politik
  • Recht
  • Sonstige Technologie
  • Sonstiges
  • Sport
  • Steuern
  • Telekommunikation
  • Termine
  • Unternehmen
  • Wissenswertes
Filter zurücksetzen

Nachrichten Seite 1.126

28. Oktober 2026 08:00 Positiv
Sandoz reports strong biosimilar-sales momentum; narrowed full-year net-sales range and upgrade to margin guidance
Sandoz Group AG / Key word(s): Sales Result Sandoz reports strong biosimilar-sales momentum; narrowed full-year net-sales range and upgrade to margin guidance 28-Oct-2026 / 07:00 CET/CEST Release of an ad …
Quelle: wallstreet-online.de

28. Oktober 2026 08:00 Positiv
DKSH Expands its Healthcare Own Brands Portfolio With the Acquisition of Rocephin® From Roche
DKSH Management Ltd. [weiter]
Quelle: ariva.de

28. Oktober 2026 08:00 Neutral
Roche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesothelioma
The VENTANA BAP1 (SP527) test helps confidently distinguish malignant mesothelioma from lung, breast and stomach cancers, as well as benign tissue growth in the chest or abdomen.Most patients are diagnosed …
Quelle: ariva.de


28. Oktober 2026 08:00
Stepan Reports Third Quarter 2026 Results
[weiter]
Quelle: ariva.de


28. Oktober 2026 08:00 Neutral
Idorsia initiates pivotal Phase 3 study for lucerastat in Fabry disease and enters co-development and commercialization agreement with Nxera
FAB-KLEAR investigates lucerastat as a potential disease-modifying therapy targeting the kidney manifestations of Fabry disease. Nxera will contribute to development and hold commercialization rights in Japan and selected Asia Pacific …
Quelle: ariva.de


28. Oktober 2026 08:00 Positiv
Arcadis Q3 2026 Trading Update: Accelerating growth and improved profitability
PRESS RELEASE | Arcadis Third Quarter 2026 Trading Update Accelerating growth and improved profitability [weiter]
Quelle: ariva.de

28. Oktober 2026 08:00
Terex Reports Third Quarter 2026 Results
[weiter]
Quelle: ariva.de

28. Oktober 2026 08:00
International Paper Reports Third Quarter 2026 Results
[weiter]
Quelle: ariva.de

28. Oktober 2026 08:00 Positiv
Corbion delivers strong volume-led sales growth and significant margin improvement in Q3; full-year guidance maintained
Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through the application of science, today publishes its results for the first nine months and third quarter of 2026. Key highlights …
Quelle: ariva.de

28. Oktober 2026 08:00
ADP Reports First Quarter Fiscal 2027 Results
[weiter]
Quelle: ariva.de

28. Oktober 2026 08:00
Etsy, Inc. Reports Third Quarter 2026 Results
[weiter]
Quelle: ariva.de

28. Oktober 2026 08:00
OGE Energy Corp. reports third quarter 2026 results
[weiter]
Quelle: ariva.de

16.876 bis 16.890 von 56.984 Ergebnissen